KPRX NASDAQ
Kiora Pharmaceuticals, Inc.
1W: -2.7%
1M: -1.2%
3M: +0.4%
YTD: +26.7%
1Y: -9.5%
3Y: -48.3%
5Y: -99.6%
$2.56
-0.02 (-0.78%)
Weekly Expected Move ±4.7%
$2
$2
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$25K
-100.2% ▼
Operating Income
-$9M
-309.7% ▼
Net Income
-$11M
-401.4% ▼
EPS (Diluted)
$-2.64
-403.4% ▼
EBITDA
-$9M
-265.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $16M | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $25K |
| Gross Profit | $0 | $0 | $0 | $16M | -$25K |
| Gross Margin | — | — | — | 100.0% | — |
| R&D Expenses | $5M | $3M | $4M | $5M | $11M |
| SG&A Expenses | $5M | $8M | $5M | $6M | $6M |
| Operating Expenses | $14M | $12M | $13M | $11M | $9M |
| Operating Income | -$14M | -$12M | -$13M | $5M | -$9M |
| Operating Margin | — | — | — | 28.2% | — |
| Interest Expense | $7K | $9K | $11K | $21K | -$20K |
| Income Before Tax | -$14M | -$14M | -$12M | $6M | -$12M |
| Tax Expense | -$193K | -$113K | $90K | $2M | -$1M |
| Net Income | -$14M | -$14M | -$13M | $4M | -$11M |
| Net Margin | — | — | — | 22.5% | — |
| EPS (Diluted) | $-68.00 | $-18.55 | $-24.25 | $0.87 | $-2.64 |
| EBITDA | -$14M | -$14M | -$12M | $6M | -$9M |
| Shares Outstanding | 241099 | 732303 | 538007 | 4M | 4M |